Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Filings indexed 965 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Medivir announces first patient enrolled in FLEX-HCC study
Regulatory Filings Classification · 65% confidence The document is a corporate press release announcing clinical trial enrollment (FLEX-HCC study), with no financial results, management changes, governance details, or investor presentation materials. It does not fit any specific category such as earnings release, capital update, M&A, or interim report. It is a general regulatory announcement required under EU Market Abuse Regulation, so it falls under the fallback category for miscellaneous regulatory filings.
2026-05-21 English
Medivir meddelar att första patienten har inkluderats i FLEX-HCC-studien
Regulatory Filings Classification · 80% confidence The document is a corporate press release announcing the inclusion of the first patient in a Phase 2 clinical trial. It contains no financial statements, no earnings or management changes, and is not presenting any formal report. It is a mandatory disclosure under EU Market Abuse Regulation, fitting the “Regulatory Filings” fallback category for miscellaneous announcements. Therefore, it should be classified as RNS.
2026-05-21 Swedish
Resolutions at the Annual General Meeting in Medivir on 7 May 2026
Regulatory Filings
2026-05-07 English
Beslut vid årsstämma i Medivir den 7 maj 2026
Regulatory Filings
2026-05-07 English
Quarterly Report 2026
Quarterly Report
2026-05-05 Swedish
Quarterly Report 2026
Quarterly Report
2026-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.